Jessica Garcia/LinkedIn
Jul 13, 2026, 18:42
Jessica Garcia: Thrombin Generation in Type 3 VWD With an Inhibitor on Emicizumab
Jessica Garcia, Pediatric Hematologist, Hemostasis and Thrombosis Specialist at UT Southwestern Medical Center, shared a post on LinkedIn:
“Honored to present at International Society on Thrombosis and Haemostasis (ISTH) this year in Paris.
Our poster highlighted thrombin generation patterns in a patient with type 3 VWD with inhibitor on emicizumab prophylaxis, including both in vitro spiking with recombinant FVIIa and in vivo peri‑operative data.
A great discussion on how global assays can capture (and sometimes challenge) what we expect clinically.”
More posts featuring Jessica Garcia on Hemostasis Today.
-
Jul 13, 2026, 18:19Fionnuala Ní Áinle: High-Quality Evidence for DVT Diagnosis in Pregnancy at ISTH 2026
-
Jul 13, 2026, 17:39Pascal Boulanger: Send a Postcard to Your Lab Staff From ISTH 2026
-
Jul 13, 2026, 17:21Stefano Navarro: Presenting Our Recently Published Article at ISTH 2026
-
Jul 13, 2026, 17:12Santagata Davide: A Great Session and an Incredible Opportunity to Present Our Research at ISTH 2026
-
Jul 13, 2026, 16:26Real-World Data Across Time Reveal Important Advances in Hemophilia Treatment – ATHN
-
Jul 13, 2026, 16:19Mary Cushman: Celebrating Our Incredible ISTH Council Members in Paris
-
Jul 13, 2026, 16:17Wolfgang Miesbach: Gene Therapy Shows Promising Early Results in Adolescents With Hemophilia B at ISTH 2026
-
Jul 13, 2026, 16:06Dino Mehic: Honored to Receive the ISTH Early Career Top Reviewer Awards
-
Jul 13, 2026, 16:01Advancing DIC Diagnosis in Cirrhosis Through Disease-Specific Risk Stratification – JTH